Good news - we have updated our site profiles

We are pleased to announce that we have updated our online profiles, as part of our commitment to improving the clinical trial experience.  Our updated profiles are now available for both investigators and site staff. Learn more

Our updated profile means

Introducing the Investigator Databank

The Investigator Databank is a global collaboration between Janssen, Lilly, Merck, Pfizer and Novartis (with more companies to come), that aims to reduce administrative burden for investigators and to increase visibility of qualified investigators to research sponsors. Hosted by a 3rd party, DrugDev, the Investigator Databank is the one place where pharmaceutical companies can share investigator and site information and investigators can view, edit, and comment on their own information.

How does the Investigator Databank work?

Industry members share information from their clinical trial management systems including investigator/site contact details, GCP training records, past trial participation, and recruitment history. Upon investigator opt-in, this information is used by each participating company to identify sites for upcoming studies; to help set recruitment targets and timelines; and to share start-up documents such as CV, GCP, and site profile forms.Typical information that you routinely share with sponsors about trial site infrastructure, GCP training records, past trial participation, and enrolment will be included in the Investigator Databank. No patient-level data are shared.


Who is in the Investigator Databank?

Geographic location of participating investigators:
Therapeutic focus of participating investigators:
Cardiovascular 21.2%
Oncology 13.2%
Neurology 13.2%
Endocrinology/Diabetes 12.2%
Pulmonary/Respiratory 8.8%
Infectious Disease 8.6%
Rheumatology 6.8%
Psychiatry 5.6%
Hematology 3.8%
Gastrointestinal 3.0%
Dermatology 2.9%
Opthalmology 2.8%

Am I in the Records of a Member Company or DrugDev?

Become a part of the Investigator Databank to decrease your administrative burden on study start-up; increase your visibility to more industry sponsors for study opportunities; and view, edit, and comment on your information stored in participating company clinical trial management systems.

Search for my records

“I am very excited and happy with this news. For a long time I have claimed and written, while filling feasibilities, about the loss of my time. I believe the steps taken as enumerated would help all the stake holders in the drug development.”

Investigator, Brazil